NCT02748902View on ClinicalTrials.gov

Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands.

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 27, 2016

Primary Completion Date

January 27, 2017

Study Completion Date

March 30, 2017

Conditions
Verruca VulgarisCommon Warts
Interventions
DRUG

ingenol mebutate 0.05% gel

Ingenol mebutate 0.05% gel applied to a minimum of two and a maximum of five common warts on days 1 and 2.

Trial Locations (1)

92123

Therapeutics Clinical Research, San Diego

Sponsors

Collaborators (1)

LEO Pharma
All Listed Sponsors
collaborator

LEO Pharma

INDUSTRY

lead

Neal D. Bhatia, MD

OTHER

NCT02748902 - Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands. | Biotech Hunter | Biotech Hunter